EUVIMEDEUVIMED entdecken
Crossref

Targeting ROS-metabolism dual pathways to trigger PANoptosis by cobalt–vanadium oxides biomimetic nanocakes for tumor immunotherapy

Silin Du, Guangyu Ma, Xiang Li, Minghao Chao, Liying Fan, Zhiqiang Zhao, Rongze Tang, Junjie Li, Chaonan Jing, Yufan Liu, Dehong Yu, Zhao Liu und 1 weitere

Biomaterials · 2026

DOI: 10.1016/j.biomaterials.2025.123726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials, 2026. Verfasst von Silin Du und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Breast Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China; Jiangsu Key Laboratory of New …. Hauptthemen laut MEDLINE: Immunotherapy. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Graduate Research and Innovation Projects of Jiangsu Province, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To overcome the resistance of tumor cells to death through a single pathway, PANoptosis, a novel synergistic mode of cell death, can simultaneously activates pyroptosis, apoptosis, and necroptosis. Most current strategies for inducing PANoptosis focused on amplifying reactive oxygen species (ROS) through exogenous stimuli, while the regulatory role of tumor cell metabolic characteristic in this process has long been overlooked. We propose a ROS-Metabolism dual axis synergistic induction of PANoptosis, simultaneously enhancing antitumor immune responses, and construct a novel bionic nanoplatform named CVOVM. This platform consists of CoVOx nanocakes and the glutamine transporter inhibitor V-9302, with 4T1 cell membranes as camouflage. In tumors, CVOVM initiates a series of catalytic reactions: CoVOx promotes numerous ROS generation, while V-9302 disrupts glutamine metabolism, depleting glutathione (GSH) and nicotinamide adenine dinucleotide (NAD+), thereby triggering the assembly of PANoptosome primarily composed of NLRP3 and NLRC5, which initiates pyroptosis, apoptosis, and necroptosis. The occurrence of PANoptosis promotes immunogenic cell death (ICD) to remodel tumor immunosuppressive microenvironment, and enhances immunotherapy and inhibits lung metastasis. Overall, we present a previously unreported mechanis to achieve the synergistic induction of PANoptosis through ROS amplification and metabolic inhibition, enhancing antitumor immunity, and potentially providing new opportunities and possibilities for combination cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyReactive Oxygen SpeciesCobaltNecroptosisPyroptosisNeoplasmsNADApoptosisBiomimetic MaterialsHumansAnimalsMiceMice, Inbred BALB CFemale

Stichwörter der Autor:innen

CobaltGlutamine metabolismImmunotherapyPANoptosisVanadium

Substanzen

Reactive Oxygen SpeciesCobaltNAD

Autor:innen und Institutionen

  • Department of Thyroid and Breast Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou…
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China.
  • Department of Orthopedics, The Affiliated Huai'an Hospital of Xuzhou Medical University, The Second People's Hospital of Huai'an, Huai'an, 223002, China.
  • Department of Orthopaedic Surgery, Lishui Central Hospital and Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, 323000, Zhejiang Province, China.
  • Department of Oncology, The Affiliated Pizhou Hospital of Xuzhou Medical University, Pizhou, Jiangsu, 221399, China. Electronic address: 15380117222@163.com.

Förderung

  • Graduate Research and Innovation Projects of Jiangsu Province
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Du, S., Ma, G., Li, X., Chao, M., Fan, L., Zhao, Z., Tang, R., Li, J., Jing, C., Liu, Y., Yu, D., Liu, Z., & Gao, F. (2026). Targeting ROS-metabolism dual pathways to trigger PANoptosis by cobalt–vanadium oxides biomimetic nanocakes for tumor immunotherapy. Biomaterials. https://doi.org/10.1016/j.biomaterials.2025.123726

Vancouver

Du S, Ma G, Li X, Chao M, Fan L, Zhao Z, et al. Targeting ROS-metabolism dual pathways to trigger PANoptosis by cobalt–vanadium oxides biomimetic nanocakes for tumor immunotherapy. Biomaterials. 2026. doi:10.1016/j.biomaterials.2025.123726

BibTeX
@article{Du2026,
  author = {Du, Silin and Ma, Guangyu and Li, Xiang and Chao, Minghao and Fan, Liying and Zhao, Zhiqiang and Tang, Rongze and Li, Junjie and Jing, Chaonan and Liu, Yufan and Yu, Dehong and Liu, Zhao and Gao, Fenglei},
  title = {Targeting ROS-metabolism dual pathways to trigger PANoptosis by cobalt–vanadium oxides biomimetic nanocakes for tumor immunotherapy},
  journal = {Biomaterials},
  year = {2026},
  doi = {10.1016/j.biomaterials.2025.123726}
}
Kostenlos starten →